• 中国精品科技期刊
  • 中国高校百佳科技期刊
  • 中国中文核心期刊
  • 中国科学引文数据库核心期刊
Advanced Search
LI Jingjing, TAN Jingfu, YANG Jie, WANG Qiang. Pharmacokinetic study of corosolic acid in normal rats and diabetic rats by LC-MS[J]. Journal of China Pharmaceutical University, 2014, 45(1): 84-87. DOI: 10.11665/j.issn.1000-5048.20140115
Citation: LI Jingjing, TAN Jingfu, YANG Jie, WANG Qiang. Pharmacokinetic study of corosolic acid in normal rats and diabetic rats by LC-MS[J]. Journal of China Pharmaceutical University, 2014, 45(1): 84-87. DOI: 10.11665/j.issn.1000-5048.20140115

Pharmacokinetic study of corosolic acid in normal rats and diabetic rats by LC-MS

More Information
  • An LC-MS method for quantification of corosolic acid in the plasma of rats was developed to investigated the pharmacokinetics of corosolic acid in normal and diabetic rats. Corosolic acid(170 mg/kg)was orally administered to normal rats and the diabetic rats induced by streptozotocin respectively. Blood samples were obtained from the oculic horioideae vein before and after dosing at selected intervals. The concentrations of corosolic acid were determined by LC-MS and the concentration-time data were analyzed by non-compartmental method using DAS 2. 0 software. Doublet peaks were shown in both normal and diabetic rats. The cmax and AUC0-24 h were significantly increased, t1/2 was remarkably prolonged and CL/F was observably decreased compared with those in the normal rats. The status of diabetes mellitus could alter the pharmacokinetics of corosolic acid in rats. The result obtained from the present study could provide reference for the evaluation of its relevant clinical efficacy.
  • [1]
    Shaw JE,Sicree RA,Zimmet PZ.Global estimates of the prevalence of diabetes for 2010 and 2030[J].Diabetes Res Clin Pract,2010,87(1):4-14.
    [2]
    Engelgau MM,Geiss LS,Saaddine JB,et al.The evolving diabetes burden in the United States[J].Ann Intern Med,2004,140(11):945-950.
    [3]
    Kudo T,Shimada T,Toda T,et al.Altered expression of CYP in TSOD mice:a model of type 2 diabetes and obesity[J].Xenobiotica,2009,39(12):889-902.
    [4]
    Kim YC,Oh EY,Kim SH,et al.Pharmacokinetics and pharmacodynamics of intravenous to rasemide in diabetic ratsinduced by alloxan or streptozotocin[J].Biopharm Drug Dispos,2005,26(8):371-378.
    [5]
    Miura T,Ueda N,Yamada K,et al.Antidiabetic effects of corosolic acid in KK-Ay diabetic mice[J].Biol Pharm Bull,2006,29(3):585-587.
    [6]
    Srinivasan K,Viswanad B,Asrat L,et al.Combination of high-fat diet-fed and low-dose streptozotocin-treated rat:a model for type 2 diabetes and pharmacological screening[J].Pharmacol Res,2005,52(4):313-320.
    [7]
    Liu Q,Zhao D,Chen X,et al.Determination of corosolic acid,a natural potential anti-diabetes compound in rat plasma by high-performance liquid chromatography-mass spectrometry and its application to pharmacokinetic and bioavailability studies[J].Planta Med,2011,77(15):1 707-1 711.
    [8]
    Lehr T,Staab A,Tillmann C,et al.A quantitative enterohepatic circulation model:development and evaluation with tesofensine and meloxicam[J].Clin Pharmacokinet,2009,48(8):529-542.
    [9]
    Salgin B,Ong KK,Thankamony A,et al.Higher fasting plasma free fatty acid levels are associated with lower insulin secretion in children and adults and a higher incidence of type 2 diabetes[J].J Clin Endocrinol Metab,2012,97(9):3 302-3 309.
    [10]
    CohenMP,Ziyadeh FN,Chen S.Amadori-modified glycated serum proteins and accelerated atherosclerosis in diabetes:pathogenic and therapeutic implications[J].J Lab Clin Med,2006,147(5):211-219.
    [11]
    Prashanth M,Ganesh HK,Vima MV,et al.Prevalence of nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus[J].J Assoc Physicians India,2009,57:205-210.
    [12]
    Zhuo L,Zou G,Li W,et al.Prevalence of diabetic nephropathy complicating non-diabetic renal disease among Chinese patients with type 2 diabetes mellitus[J].Eur J Med Res.2013,18(1): 4-11.
  • Related Articles

    [1]Ocular pharmacokinetics of methazolamide ophthalmic suspension in rabbit aqueous humor[J]. Journal of China Pharmaceutical University, 2010, 41(4): 337-341.
    [2]Comparative pharmacokinetics of aconitine, mesaconitine and hypaconitine in rats after oral administration of four decoctions composed with Radix Aconiti Lateralis[J]. Journal of China Pharmaceutical University, 2010, 41(1): 55-59.
    [3]Pharmacokinetics of Osthole in Rabbits with Impaired Renal Function[J]. Journal of China Pharmaceutical University, 2004, (3): 54-56.
    [4]High-throughput Screening Approaches for New Drug Metabolism and Pharmacokinetics[J]. Journal of China Pharmaceutical University, 2003, (4): 1-5.
    [5]Pharmacokinetic of Behaviors Transdermal Delivery and Oral Administration of Cyclosporin A Preparations in Mice[J]. Journal of China Pharmaceutical University, 2000, (5): 20-23.
    [6]Determinationof Omeprazole in Human Plasma by Capillary Electrophoresis and Clinical Application[J]. Journal of China Pharmaceutical University, 2000, (1): 31-34.
    [7]Studies on Pharmacokinetics of Guaifenesin in Rabbits Plasma[J]. Journal of China Pharmaceutical University, 1998, (4): 58-60.
    [8]Study on Sustained Release Tablets of Salbutamol Sulfate and Its Pharmacokinetics in Healthy Human Volunteers[J]. Journal of China Pharmaceutical University, 1997, (5): 26-29.
    [9]Studies on Benorylate Capsules Formulation and Their Pharmacokinetics in Man[J]. Journal of China Pharmaceutical University, 1997, (3): 21-24.
    [10]HPLC Determination of Isosorbide-5-mononitrate Tablets[J]. Journal of China Pharmaceutical University, 1993, (4): 229-230.

Catalog

    Article views (1444) PDF downloads (1869) Cited by()

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return